The effects of anti-diabetic drugs on LDL subclasses: any role for colesevelam?

Cardiovasc Drugs Ther. 2014 Jun;28(3):205-7. doi: 10.1007/s10557-014-6521-1.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Allylamine / analogs & derivatives*
  • Allylamine / therapeutic use
  • Anticholesteremic Agents / therapeutic use*
  • Colesevelam Hydrochloride
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Female
  • Humans
  • Lipoproteins / blood*
  • Male

Substances

  • Anticholesteremic Agents
  • Lipoproteins
  • Allylamine
  • Colesevelam Hydrochloride